USP Group completes production trial run of new hand sanitiser, to be given to needy

SII Scientific, a subsidiary of watch-listed USP Group, has concluded a successful production trial of its new hand sanitiser.

USP said in a bourse filing on Tuesday that the hand sanitiser contains 70 per cent ethanol.

In light of the current Covid-19 spread, the company will distribute the product to the needy and to old folks' homes in Singapore as part of its corporate social responsibility initiative.

USP said that production of the hand sanitiser, coupled with sales of its IQAir purifier, will help it better penetrate the healthcare sector in the region. The group is the sole distributor for the IQAir purifier in Singapore and Indonesia.

Commercial production of the hand sanitiser, branded as "Impact", is projected to start by the second quarter of 2021.

The launch of the hand sanitiser is not expected to have any material impact on USP's net tangible assets and earnings per share for the financial year ending March 31, 2021.

THE BUSINESS TIMES INSIGHTS

Powering Asean's Future 2026

Find out how enterprises are navigating power constraints and sustainability targets

ACCESS THE INSIGHTS

The counter last traded on March 17 at 7.8 Singapore cents.